Why Viatris Stock Rocketed Higher in May

12:29pm, Tuesday, 08'th Jun 2021
This undervalued dividend stock finally found its footing in May.

2 Best Value Stocks to Buy Now

08:47am, Monday, 31'st May 2021
Looking for solid companies trading on the cheap? Here are your top bets!
Viatris has demonstrated some headwinds in its inaugural quarter, but I don't see this as being unique, as peers have also seen revenue declines. An improving COVID environment and the pipeline of hig

3 Great Stocks to Own in a Stock Market Crash

06:04am, Sunday, 30'th May 2021
All of these stocks could be attractive ports in the next market storm for very different reasons.

Is Viatris a Good Stock to Buy for 2021?

06:01am, Sunday, 30'th May 2021
Long-term investors might want to consider adding this recently formed pharmaceutical company to their portfolios.

Why Is No One Talking About Viatris Stock?

08:21am, Thursday, 27'th May 2021
This company is one of the largest manufacturers of generic pharmaceuticals in the world, but it may be underpriced.
PITTSBURGH, May 25, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conferenc
Viatris' (VTRS) Management Presents at RBC capital marketsConference (Transcript)
Dividend Stock Purchase: Lanny's April 2021 Summary
Richard Pzena (Trades, Portfolio)'s Pzena Investment Management LLC sold shares of the following stocks during the first quarter of 2021, which ended on March 31.

Smead Value Fund Buys Chevron, Viatris

11:33am, Wednesday, 12'th May 2021
Smead Value Fund (Trades, Portfolio) sold shares of the following stocks during the first quarter of 2021, which ended on March 31.
Viatris' (VTRS) CEO Michael Goettler on Q1 2021 Results - Earnings Call Transcript
Viatris (VTRS) beats on Q1 earnings while sales surpass expectations. The company announces inaugural quarterly dividend.
Viatris Inc (NASDAQ: VTRS) reported Q1 net sales of $4.4 billion, down 6% Y/Y on a reported basis, but only down 2% compared to a combined loss of exclusivity. The sales beat the consensus of $4.1
PITTSBURGH, May 10, 2021 /PRNewswire/ -- Reports First Quarter 2021 Financial Results - Total Revenue of $4.4 billion, U.S. GAAP net loss of $1.0 billion, Adjusted EBITDA of $1.6 billion, U.S. GAAP ne
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE